Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.
Quantitative Sensory testing at baseline and during cycle 1 Detects subclinical peripheral neuropathy and Predicts clinically overt chronic neuropathy in gastrointestinal malignancies